The Montreal Cognitive Assessment (MoCA) as a screening test for cognitive dysfunction in multiple sclerosis. (Q48267703)

10 February 2018

title

The Montreal Cognitive Assessment (MoCA) as a screening test for cognitive dysfunction in multiple sclerosis. (English)

1 reference

10 February 2018

main subject

cognitive dysfunction

1 reference

Sónia Batista

2

0 references

Mário R. Simões

object named as

Mário R Simões

4

0 references

author name string

Sandra Freitas

1

1 reference

10 February 2018

Ana Cristina Afonso

3

1 reference

10 February 2018

Lívia de Sousa

5

1 reference

10 February 2018

Luís Cunha

6

1 reference

10 February 2018

Isabel Santana

7

1 reference

10 February 2018

publication date

28 October 2016

1 reference

10 February 2018

Applied neuropsychology. Adult

published in

1 reference

10 February 2018

volume

25

1 reference

10 February 2018

page(s)

57-70

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

Premorbid IQ influence on screening tests' scores in healthy patients and patients with cognitive impairment.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Cognitive impairment is associated with reduced bone mass in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Reliable screening for neuropsychological impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Cross cultural validation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Validity and reliability of a Persian translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Psychometric properties of the Montreal Cognitive Assessment (MoCA): an analysis using the Rasch model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Montreal Cognitive Assessment (MoCA): validation study for frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Montreal Cognitive Assessment (MoCA): normative study for the Portuguese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Montreal Cognitive Assessment (MoCA): validation study for vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Construct Validity of the Montreal Cognitive Assessment (MoCA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." A Canadian perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Paced auditory serial-addition task: a measure of recovery from concussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Immunopathogenesis and immunotherapy of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

A model of equivalence in the cultural adaptation of HRQoL instruments: the universalist approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Quick screening of cognitive function in Indian multiple sclerosis patients using Montreal cognitive assessment test-short version

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Fatigue and declines in cognitive functioning in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Cognition in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Prospective comparison of the prognostic utility of the Mini Mental State Examination and the Montreal Cognitive Assessment in patients with brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

The cognitive performance of patients with multiple sclerosis during periods of high and low fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Cognitive impairment differs between primary progressive and relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Uses and abuses of coefficient alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Cross-cultural Adaptation, Reliability, and Validity of the BICAMS in Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

The influence of pre-morbid IQ on Mini-Mental State Examination score at time of dementia presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Starting at the beginning: an introduction to coefficient alpha and internal consistency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F23279095.2016.1243108

10.1080/23279095.2016.1243108

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

release_tf5kzhqnnnf5nkyryzywt2hqj4

Fatcat ID

0 references

PubMed ID

27791389

1 reference

10 February 2018